Skip to content
About Prolight
Market
Partnerships
Board of Directors and Management
Clinical Advisory Board
History
Cutting-edge technology
Vision & strategy
Products
Psyros™
MicroFlex
Patents
Investors
Press releases
Financial reports
CEO comment
Financial calendar
Stock information
AGM
Shareholders
Key figures
Corporate governance
Prospectus
Media
Press releases
Investor letters
Media gallery
Presentations
Articles
Contact us
About Prolight
Market
Partnerships
Board of Directors and Management
Clinical Advisory Board
History
Cutting-edge technology
Vision & strategy
Products
Psyros™
MicroFlex
Patents
Investors
Press releases
Financial reports
CEO comment
Financial calendar
Stock information
AGM
Shareholders
Key figures
Corporate governance
Prospectus
Media
Press releases
Investor letters
Media gallery
Presentations
Articles
Contact us
EN
SV
Press releases
Category
All
Regulatory
Non-Regulatory
Interim
Annual
Year
All
2025
2024
2023
2022
2025
2025-05-28 11:55
Biostock publishes article about the positive pre-clinical results and coming milestone for Prolight Diagnostics in Q2
2025-05-26 18:15
NOTICE OF THE ANNUAL GENERAL MEETING IN PROLIGHT DIAGNOSTICS AB (PUBL)
Regulatory
2025-05-23 08:25
Emergers publishes updated analysis about Prolight Diagnostics
2025-05-21 18:45
NOTICE OF EXTRAORDINARY GENERAL MEETING IN PROLIGHT DIAGNOSTICS AB (PUBL)
Regulatory
2025-05-21 18:25
Prolight has resolved on a rights issue of shares to complete the development of the Point of Care system Psyros™ and reach commercialisation
Regulatory
MAR
2025-05-09 08:00
Prolight receives new MicroFlex patent approval in the US
2025-04-28 08:00
Prolight secures first two European patents for Psyros™ technology
2025-04-23 10:45
Study highlights speed of biomarker integration on Psyros POC platform
2025-03-31 08:00
Prolight announces positive pre-clinical data
Regulatory
MAR
2025-03-26 08:00
Prolight receives notice of allowance for MicroFlex patent
Next
